Mediomics, LLC Receives Phase II SBIR Contract: Awarded $969,770 to develop high affinity antibodies for site-specific detection of protein O-glycosylation
Mediomics, LLC Receives Phase II SBIR Contract: Awarded $969,770 to develop high affinity antibodies for site-specific detection of protein O-glycosylation